glp 1 agonist cardioprotective Cardiovascular effects of Glucagon-like peptide (GLP-1) receptor agonists | Cardiovascular Diabetology GLP-1 receptor agonists were developed

In clinical trials, it led to a weight reduction of up to 16.2%

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors

The concern regarding how GLP-1 medications affect birth control has to do with the fact that these medications significantly impact the rate of ....

These milestones will redefine how obesity care is delivered, marking a turning point that will shape the markets trajectory for 2026 and the years to come

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.